Skip to navigation
Skip to main content
Menu
Close
Search...
Submit
Cancer Types
Open Submenu
Cancer Types
Back
Brain Cancer
Breast Cancer
Cervical Cancer
Chronic Myeloid Leukemia
Colorectal Cancer
Gastrointestinal Cancer
General Oncology
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Hematologic Cancers
Kidney Cancer
Leukemia
Liver Cancer
Lung Cancer
Lymphoma
Melanoma
Multiple Myeloma
Myeloproliferative Neoplasms
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
Hot Topics
Open Submenu
Hot Topics
Back
Advisor Forum
Ask a Pharmacist
Ask the Experts
Communication Challenges
Complementary and Alternative Medicine
From CancerCare
Issues in Cancer Survivorship
Journal Review
Navigation
Oncology Nursing
Radiation and Your Patient
Reflections
Side-Effect Management
Stat Consult
The Patient’s Voice
The Total Patient
Regimens
Resources
Open Submenu
Resources
Back
Clinical Tools
Clinical Charts
Drug Information Database
Medical Calculators
Professional Resources
Expert Perspective
Decision Support in Medicine
Digital Issues
Job Board
Product Directory
Useful Links
For Patients
Open Submenu
For Patients
Back
Advocacy
Cancer Support Groups
Fact Sheets
Finding Clinical Trials
Conferences
Open Submenu
Conferences
Back
Oncology Conferences
Conference Coverage
ASCO 2020
ONA Virtual Navigation Summit 2020
ONS Bridge 2020
SABCS 2019
News Resources
Daily Oncology News
Web Exclusives
Navigation Summit
Toggle Search Menu
News
CE
Fact Sheets
Publishers Alliance
Navigation
Expert Perspective
Slideshows
Jobs
Login
Register
Generic Drugs
»
P
Browse Drugs By Generic
Select Drugs A-Z
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
P-PC
PD-PE
PF-PI
PJ-PM
PN-PO
PP-PR
PS-PT
PY-PZ
Generic Drugs
P-PC
Drug Name
PABA
SOLAQUIN
Pigmentation disorders
Paclitaxel
Paclitaxel
Breast cancer
Gynecologic cancers
Kaposi's sarcoma
Respiratory and thoracic cancers
Paclitaxel, protein-bound
ABRAXANE
Breast cancer
Pancreatic, thyroid, and other endocrine cancers
Respiratory and thoracic cancers
Padimate O
SOLAQUIN FORTE
Pigmentation disorders
SOLAQUIN FORTE GEL
Pigmentation disorders
Palbociclib
IBRANCE
Breast cancer
Palifermin
KEPIVANCE
Cytoprotective and supportive care agents
Paliperidone
INVEGA
Psychosis
INVEGA SUSTENNA
Psychosis
INVEGA TRINZA
Psychosis
Palivizumab
SYNAGIS
Viral infections
Palonosetron
AKYNZEO
Nausea
AKYNZEO FOR INJECTION
Nausea
AKYNZEO INJECTION
Nausea
ALOXI
Nausea
Pamabrom
MIDOL
Dysmenorrhea
Pamidronate
Pamidronate disodium Injection
Bone disorders
Breast cancer
Cytoprotective and supportive care agents
Leukemias, lymphomas, and other hematologic cancers
Pancuronium
Pancuronium Bromide Injection
Anesthetics
Panitumumab
VECTIBIX
Colorectal and other GI cancers
Panobinostat
FARYDAK
Leukemias, lymphomas, and other hematologic cancers
Pantoprazole
PROTONIX
Hyperacidity, GERD, and ulcers
PROTONIX for ORAL SUSP
Hyperacidity, GERD, and ulcers
PROTONIX IV
Hyperacidity, GERD, and ulcers
Parathyroid hormone.
NATPARA
Secondary hyperparathyroidism or hypocalcemia
Paricalcitol
ZEMPLAR CAPSULES
Secondary hyperparathyroidism or hypocalcemia
ZEMPLAR INJECTION
Secondary hyperparathyroidism or hypocalcemia
Paritaprevir
VIEKIRA PAK
Viral infections
Paromomycin Sulfate
Paromomycin Sulfate
Hepatic encephalopathy
Protozoal infections
Paroxetine
BRISDELLE
Menopause and HRT
PAXIL
Anxiety/OCD
Mood disorders
PAXIL CR
Anxiety/OCD
Mood disorders
PAXIL SUSPENSION
Anxiety/OCD
Mood disorders
Pasireotide
SIGNIFOR
Pituitary disorders
SIGNIFOR LAR
Pituitary disorders
Patiromer
VELTASSA
Electrolyte disturbances
Patisiran
ONPATTRO
Inborn errors of metabolism
Miscellaneous neurodegenerative disorders
Pazopanib
VOTRIENT
Bladder, kidney, and other urologic cancers
Bone and connective tissue cancer
Already have an account? Sign in
here
Loading...
Loading...
Show More
Open
Next post in Myeloproliferative Neoplasms
Close
Comparison of Systemic Therapies for MPN Subtypes in the Real-World Setting
Close more info about Carriers of
CALR
Mutations at Decreased Risk for Thrombotic Events Among Patients With Essential Thrombocythemia
Loading...
Close more info about Carriers of
CALR
Mutations at Decreased Risk for Thrombotic Events Among Patients With Essential Thrombocythemia
Loading...